| |
News - March, 2010
The Rocky Mountain Blood and
Marrow Transplant Program is committed to ongoing
education in the field. We are providing the latest
treatment and research news around our program for
patients and their caregivers and physicians.
 |
03-04-2010 |
Targeting Leukemia Cell's Gene 'addiction' Presents New Strategy For Treatment (external link)
An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.
|
|
|
